Evidence map›Paper›PMID 41727905›Full record

ArticleFrontiers in neurology2025

Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumors.

David Bouget, Mathilde Gajda Faanes, Asgeir Store Jakola, Frederik Barkhof, Hilko Ardon, Lorenzo Bello, Mitchel S Berger, Shawn L Hervey-Jumper, Julia Furtner, Albert J S Idema and 10 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

David BougetDepartment of Health Research, SINTEF Digital, Trondheim, Norway.
Mathilde Gajda FaanesDepartment of Health Research, SINTEF Digital, Trondheim, Norway.
Asgeir Store JakolaDepartment of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden.
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
Hilko ArdonDepartment of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands.
Lorenzo BelloNeurosurgical Oncology Unit, Department of Oncology and Hemato-oncology, Humanitas Research Hospital, Milano, Italy.
Mitchel S BergerDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Shawn L Hervey-JumperDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Julia FurtnerDepartment of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Wien, Austria.
Albert J S IdemaDepartment of Neurosurgery, Northwest Clinics, Alkmaar, Netherlands.
Barbara KieselDepartment of Neurosurgery, Medical University Vienna, Wien, Austria.
Georg WidhalmDepartment of Neurosurgery, Medical University Vienna, Wien, Austria.
Rishi Nandoe TewarieDepartment of Neurosurgery, Haaglanden Medical Center, The Hague, Netherlands.
Emmanuel MandonnetDepartment of Neurological Surgery, Hôpital Lariboisiére, Paris, France.
Pierre A RobeDepartment of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, Netherlands.
Michiel WagemakersDepartment of Neurosurgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Timothy R SmithDepartment of Neurosurgery, Brigham and Women's Hospital, Boston, MA, United States.
Philip C De Witt HamerCancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Ole SolheimDepartment of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Ingerid ReinertsenDepartment of Health Research, SINTEF Digital, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Magnetic resonance (MR) imaging is essential for diagnosing central nervous system (CNS) tumors, guiding surgical planning, treatment decisions, and assessing postoperative outcomes and complications. While recent work has advanced automated tumor segmentation and report generation, most efforts have focused on preoperative data, with limited attention to postoperative imaging analysis. Methods: This study introduces a comprehensive pipeline for standardized postsurgical reporting in CNS tumors. Using the Attention U-Net architecture, segmentation models were trained, independently targeting the preoperative tumor core, non-enhancing tumor core, postoperative contrast-enhancing residual tumor, and resection cavity. In the process, the influence of varying MR sequence combinations was assessed. Additionally, MR sequence classification and tumor type identification for contrast-enhancing lesions were explored using the DenseNet architecture. The models were integrated seamlessly into an automated and standardized reporting pipeline, following the RANO 2.0 guidelines. Training was conducted on multicentric datasets comprising 2000 to 7000 patients, incorporating both private and public data, using a 5-fold cross-validation. Results: Evaluation included patient-, voxel-, and object-wise metrics, with benchmarking against the latest BraTS challenge results. The segmentation models achieved average voxel-wise Dice scores of 87%, 66%, 70%, and 77% for the tumor core, non-enhancing tumor core, contrast-enhancing residual tumor, and resection cavity, respectively. Classification models reached 99.5% balanced accuracy in MR sequence classification and 80% in tumor type classification. Discussion: The pipeline presented in this study enables robust, automated segmentation, MR sequence classification, and standardized report generation aligned with RANO 2.0 guidelines, enhancing postoperative evaluation and clinical decision-making. The proposed models and methods were integrated into Raidionics, open-source software platform for CNS tumor analysis, now including a dedicated module for postsurgical analysis.

Indexed as

3D segmentationattention U-netCNS tumorRADSreporting

Identifiers

PMID41727905
PMCPMC12920189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.